Nimbus Therapeutics - Funding, Financials, Valuation, Investors - Cointime

比特币 ¥629,196.01 -1.40%
以太坊 ¥21,127.39 -2.56%
币安币 ¥6,063.44 -2.02%
Optimism ¥1.93 -2.13%
Arbitrum ¥1.34 -1.63%
Solana ¥889.81 -1.85%
Polygon ¥1.56 +2.77%
Cosmos ¥14.20 +0.26%
Avalanche ¥86.32 -2.18%

比特币 ¥629,196.01 -1.40%
以太坊 ¥21,127.39 -2.56%
币安币 ¥6,063.44 -2.02%
Optimism ¥1.93 -2.13%
Arbitrum ¥1.34 -1.63%
Solana ¥889.81 -1.85%
Polygon ¥1.56 +2.77%
Cosmos ¥14.20 +0.26%
Avalanche ¥86.32 -2.18%

Nimbus Therapeutics

company

Investors

Number of Lead Investors

Number of Investors

7

17

Nimbus Therapeutics is funded by 17 investors. Access Biotechnology and Atlas Venture are the most recent investors.

Investor Name	Lead Investor	Funding Round
Access Biotechnology	-	Series Unknown
Atlas Venture	-	Series Unknown
Bain Capital Life Sciences	-	Series Unknown
Bill Gates	-	Series Unknown
Biotechnology Value Fund	-	Series Unknown
Lightstone Ventures	-	Series Unknown
Pfizer Venture Investments	-	Series Unknown
RA Capital Management	-	Series Unknown
SR One	-	Series Unknown
SV Health Investors	-	Series Unknown
Commodore Capital	-	Series Unknown
Logos Capital	-	Series Unknown
Surveyor Capital	-	Series Unknown
BVF Partners	-	Series Unknown
Lilly Ventures	-	Series C
Schrödinger	-	Series C
Richard Friesner	-	Seed